4.4 Article

Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics

期刊

PEPTIDES
卷 50, 期 -, 页码 19-23

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2013.09.014

关键词

Streptococcus suis; Swine infection; Nisin; Antibiotic; Synergy

资金

  1. Center de Recherche en Infectiologie Porcine et Avicole
  2. Natural Sciences and Engineering Research Council of Canada (NSERC)
  3. Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ)

向作者/读者索取更多资源

Streptococcus suis serotype 2 is known to cause severe infections in pigs, including meningitis, endocarditis and pneumonia. Furthermore, this bacterium is considered an emerging zoonotic agent. Recently, increased antibiotic resistance in S. suis has been reported worldwide. The objective of this study was to evaluate the potential of nisin, a bacteriocin of the lantibiotic class, as an antibacterial agent against the pathogen S. suis serotype 2. In addition, the synergistic activity of nisin in combination with conventional antibiotics was assessed. Using a plate assay, the nisin-producing strain Lactococcus lactis ATCC 11454 proved to be capable of inhibiting the growth of S. suis (n = 18) belonging to either sequence type( ST) 1, ST25, or ST28. In a microdilution broth assay, the minimum inhibitory concentration (MIC) of purified nisin ranged between 1.25 and 5 mu g/mL while the minimum bactericidal concentration (MBC) was between 5 and 10 mu g/mL toward S. suis. The use of a capsule-deficient mutant of S. suis indicated that the presence of this polysaccharidic structure has no marked impact on susceptibility to nisin. Following treatment of S. suis with nisin, transmission electron microscopy observations revealed lysis of bacteria resulting from breakdown of the cell membrane. A time-killing curve showed a rapid bactericidal activity of nisin. Lastly, synergistic effects of nisin were observed in combination with several antibiotics, including penicillin, amoxicillin, tetracycline, streptomycin and ceftiofur. This study brought clear evidence supporting the potential of nisin for the prevention and treatment of S. suis infections in pigs. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Antibacterial activity against porcine respiratory bacterial pathogens and in vitro biocompatibility of essential oils

Genevieve LeBel, Katy Vaillancourt, Philippe Bercier, Daniel Grenier

ARCHIVES OF MICROBIOLOGY (2019)

Article Dentistry, Oral Surgery & Medicine

Resveratrol attenuates the pathogenic and inflammatory properties of Porphyromonas gingivalis

Amel Ben Lagha, Elisoa Andrian, Daniel Grenier

MOLECULAR ORAL MICROBIOLOGY (2019)

Article Integrative & Complementary Medicine

Determination of the effects of cinnamon bark fractions on Candida albicans and oral epithelial cells

Marie-Pier Veilleux, Daniel Grenier

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Biocompatible combinations of nisin and licorice polyphenols exert synergistic bactericidal effects against Enterococcus faecalisand inhibit NF-κB activation in monocytes

Daniel Grenier, Eve Marcoux, Jabrane Azelmat, Amel Ben Lagha, Philippe Gauthier

AMB EXPRESS (2020)

Article Multidisciplinary Sciences

A polyphenolic cinnamon fraction exhibits anti-inflammatory properties in a monocyte/macrophage model

Amel Ben Lagha, Jabrane Azelmat, Katy Vaillancourt, Daniel Grenier

Summary: This study characterized the anti-inflammatory properties of a polyphenolic cinnamon fraction, showing that it reduced IL-6, IL-8, and TNF-alpha secretion in a dose-dependent manner and may prevent NF-kappa B activation induced by LPS. The cinnamon fraction also reduced LPS binding to monocytes and may act as a natural PPAR-gamma ligand, suggesting therapeutic potential for the treatment of periodontal diseases.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Effects of a tart cherry (Prunus cerasus L.) phenolic extract on Porphyromonas gingivalis and its ability to impair the oral epithelial barrier

Amel Ben Lagha, Genevieve Pellerin, Katy Vaillancourt, Daniel Grenier

Summary: Periodontal diseases, including gingivitis and periodontitis, are a global oral health problem caused by bacteria like Porphyromonas gingivalis. This study found that a phenolic extract from tart cherry juice can inhibit the growth and activities of P. gingivalis, and protect the integrity of the oral epithelial barrier.

PLOS ONE (2021)

Article Dentistry, Oral Surgery & Medicine

Production of TNF- by macrophages stimulated with endodontic pathogens and its effect on the biological properties of stem cells of the apical papilla

Pierre-Olivier Miron, Amel Ben Lagha, Jabrane Azelmat, Anibal Diogenes, Juliana Nascimento Santos, Daniel Grenier

Summary: The study found that TNF- has detrimental effects on the viability, proliferation rate, and mineralization potential of stem cells of the apical papilla. Additionally, treating SCAP with TNF- reduced the secretion of periostin and increased the secretion of various cytokines and MMPs.

CLINICAL ORAL INVESTIGATIONS (2021)

Article Dentistry, Oral Surgery & Medicine

A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell model

Katy Vaillancourt, Amel Ben Lagha, Daniel Grenier

Summary: Green tea extract and EGCG can reduce the cytotoxicity of the chemotherapeutic agent irinotecan towards oral epithelial cells, decrease intracellular ROS production, inhibit cell proliferation and migration, and suppress the secretion of cytokines and MMPs.

ARCHIVES OF ORAL BIOLOGY (2021)

Article Dentistry, Oral Surgery & Medicine

A Dual Zinc plus Arginine formulation protects against tumor necrosis factor-alpha-induced barrier dysfunction and enhances cell proliferation and migration in an in vitro gingival keratinocyte model

Amel Ben Lagha, Ying Yang, Harsh M. Trivedi, James G. Masters, Daniel Grenier

Summary: The study demonstrated that Dual Zinc plus Arginine formulations can protect the barrier integrity of gingival keratinocytes, promote cell proliferation, and enhance cell migration.

ARCHIVES OF ORAL BIOLOGY (2021)

Article Multidisciplinary Sciences

A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function

Amel Ben Lagha, Patricia Maquera Huacho, Daniel Grenier

Summary: The study demonstrated that a cocoa extract rich in epicatechin can effectively inhibit the growth, biofilm formation, adherence, and H2S production of F. nucleatum. Additionally, it showed anti-inflammatory properties, reduced IL-6 and IL-8 production, and enhanced epithelial barrier function, suggesting that it may have potential in preventing and treating periodontal diseases.

PLOS ONE (2021)

Article Biotechnology & Applied Microbiology

Identification and Characterization of a Two-Peptide Class IIb Bacteriocin in Streptococcus pluranimalium Isolated from the Nasal Cavity of a Healthy Pig

Katy Vaillancourt, Genevieve LeBel, Nahuel Fittipaldi, Michel Frenette, Marcelo Gottschalk, Daniel Grenier

Summary: In this study, a new bacteriocin produced by Streptococcus pluranimalium 2N12 was characterized. This bacteriocin, called pluranimalicin 2N12, exhibited antibacterial activity against Streptococcus suis and showed a dual action of both antibacterial and anti-inflammatory effects.

PROBIOTICS AND ANTIMICROBIAL PROTEINS (2022)

Article Infectious Diseases

Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection

Jinpeng Li, Qingying Fan, Jing Zuo, Bingqian Xue, Xiaoling Zhang, Ying Wei, Liyun Sun, Daniel Grenier, Li Yi, Xiaogai Hou, Yang Wang

Summary: This study suggests that the combination of paeoniflorin and norfloxacin can effectively combat FQ-resistant Streptococcus suis. Paeoniflorin inhibits the LuxS/AI-2 quorum sensing system and down-regulates the transcription of the FQ efflux pump gene, enhancing the bactericidal effect of norfloxacin. Additionally, paeoniflorin inhibits biofilm formation, promoting the ability of norfloxacin to kill S. suis. In a mouse model, paeoniflorin in combination with norfloxacin demonstrates efficacy in treating S. suis infections.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Biochemistry & Molecular Biology

Effect of cranberry juice deacidification on its antibacterial activity against periodontal pathogens and its anti-inflammatory properties in an oral epithelial cell model

Genevieve Pellerin, Laurent Bazinet, Daniel Grenier

Summary: The study found that removal of organic acids from cranberry juice through electrodialysis weakened its antibacterial effect against certain periodontal pathogens, but had varying effects on the adherence of these pathogens to oral epithelial cells. Additionally, deacidification of cranberry juice reduced its cytotoxicity for oral epithelial cells and attenuated its anti-inflammatory effect.

FOOD & FUNCTION (2021)

Article Biochemistry & Molecular Biology

The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice

Giovanni Pacini, Bo Ahren

Summary: Tirzepatide stimulates both insulin secretion and glucose effectiveness, with stimulation of glucose effectiveness being the prominent process to reduce glucose.

PEPTIDES (2024)

Article Biochemistry & Molecular Biology

Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice

Si -yu Wang, Yu-zhe Zhang, Xiao-han Liu, Xue-ci Guo, Xiao-fang Wang, Feng-tong Han, Yao Zhang, Chang -lin Wang

Summary: In the formalin pain test, the EM-2 analogs EM-2-Me, EM-2-Et, and EM-2-Bu showed significant analgesic effects with reduced tolerance and gastrointestinal side effects. These effects were mediated through central opioid mechanisms, with EM-2-Me possibly involving dynorphin A release and EM-2-Bu directly activating multiple opioid receptors.

PEPTIDES (2024)